Triptolide inhibits transcription of hTERT through down-regulation of transcription factor specificity protein 1 in primary effusion lymphoma cells

Biochemical and Biophysical Research Communications

Volumn 469, Issue 1, 2016, Pages 87-93

  Long, Cong ^a   Wang, Jingchao ^a   Guo, Wei ^a   Wang, Huan ^a   Wang, Chao ^a   Liu, Yu ^a   Sun, Xiaoping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

hTERT; PEL cells; Sp1; Triptolide

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SP1; TRIPTOLIDE; ALKYLATING AGENT; DITERPENE; EPOXIDE; PHENANTHRENE DERIVATIVE; SP1 PROTEIN, HUMAN; TELOMERASE;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; EMBRYO; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LYMPHOMA CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; DOWN-REGULATION; EPOXY COMPOUNDS; HUMANS; LYMPHOMA, PRIMARY EFFUSION; PHENANTHRENES; SP1 TRANSCRIPTION FACTOR; TELOMERASE; TRANSCRIPTIONAL ACTIVATION;

EID: 84950291135     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.076     Document Type: Article

References (28)

1. D.M. Knowles, G. Inghirami, A. Ubriaco, and et al. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus Blood 73 1989 792 799
2. S. Okada, H. Goto, and M. Yotsumoto Current status of treatment for primary effusion lymphoma Intractable Rare Dis. Res. 3 2014 65 74
3. E. Boulanger, L. Gerard, J. Gabarre, and et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS J. Clin. Oncol. 23 2005 4372 4380
4. D. Ding, J. Zhou, M. Wang, and et al. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer FEBS J. 280 2013 3205 3211
5. H. Holysz, N. Lipinska, A. Paszel-Jaworska, and et al. Telomerase as a useful target in cancer fighting-the breast cancer case Tumour Biol. 34 2013 1371 1380
6. C.W. Greider Telomere length regulation Annu. Rev. Biochem. 65 1996 337 365
7. L. Xu, S. Li, and B.A. Stohr The role of telomere biology in cancer Annu. Rev. Pathol. 8 2013 49 78
8. M. Gladych, A. Wojtyla, and B. Rubis Human telomerase expression regulation Biochem. Cell Biol. 89 2011 359 376
9. A. Tallet, J.C. Nault, A. Renier, and et al. Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma Oncogene 33 2014 3748 3752
10. M.H. Lu, Z.L. Liao, X.Y. Zhao, and et al. hTERT-based therapy: a universal anticancer approach (Review) Oncol. Rep. 28 2012 1945 1952
11. S.M. Kupchan, W.A. Court, R.G. Dailey, and et al. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii J. Am. Chem. Soc. 94 1972 7194 7195
12. Z.L. Zhou, Y.X. Yang, J. Ding, and et al. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms Nat. Prod. Rep. 29 2012 457 475
13. S. Banerjee, V. Sangwan, O. McGinn, and et al. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1 J. Biol. Chem. 288 2013 33927 33938
14. R. Chugh, V. Sangwan, S.P. Patil, and et al. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer Sci. Transl. Med. 4 2012 156ra139
15. H. Zhou, W. Guo, C. Long, and et al. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1 Biochem. Biophys. Res. Commun. 456 2015 815 820
16. J.S. Knight, M.A. Cotter II, and E.S. Robertson The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter J. Biol. Chem. 276 2001 22971 22978
17. J.M. Berg Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites Proc. Natl. Acad. Sci. U. S. A. 89 1992 11109 11110
18. S.C. Verma, S. Borah, and E.S. Robertson Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1 J. Virol. 78 2004 10348 10359
19. T. Ohira, S. Naohiro, Y. Nakayama, and et al. miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells Sci. Rep. 5 2015 8201
20. B. Herbert, A.E. Pitts, S.I. Baker, and et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death Proc. Natl. Acad. Sci. U. S. A. 96 1999 14276 14281
21. X. Zhang, V. Mar, W. Zhou, and et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells Genes Dev. 13 1999 2388 2399
22. K. Hoffmeyer, A. Raggioli, S. Rudloff, and et al. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells Science 336 2012 1549 1554
23. A. Ghosh, G. Saginc, S.C. Leow, and et al. Telomerase directly regulates NF-kappaB-dependent transcription Nat. Cell Biol. 14 2012 1270 1281
24. Y. Zhang, M. Sun, W. Shi, and et al. Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells Toxicol. Lett. 232 2015 481 489
25. S.L. Palumbo, S.W. Ebbinghaus, and L.H. Hurley Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands J. Am. Chem. Soc. 131 2009 10878 10891
26. S. Kyo, M. Takakura, T. Taira, and et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res. 28 2000 669 677
27. K. Kraemer, S. Fuessel, U. Schmidt, and et al. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin. Cancer Res. 9 2003 3794 3800
28. M. Folini, C. Brambilla, R. Villa, and et al. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells Eur. J. Cancer 41 2005 624 634